BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

September 5, 2019

BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System

August 1, 2019

Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs

July 24, 2019

Olivier Chaudoir Joins BioSig as Director of Marketing

July 18, 2019

Manasi Patwardhan Joins BioSig as Director of Strategic Planning

July 11, 2019

BioSig Technologies, Inc. Added to Membership of Russell 3000® Index

July 1, 2019

Samuel E. Navarro Appointed to BioSig Board of Directors

June 25, 2019

BioSig Technologies Issues June 2019 Shareholder Letter

June 20, 2019

BioSig Technologies Set to Join Russell 3000® Index

June 10, 2019

BioSig Allowed a U.S. Patent for PURE EP™ Simulator

June 6, 2019